ADPT
Price
$24.42
Change
+$0.47 (+1.96%)
Updated
Oct 20 closing price
Capitalization
3.9B
14 days until earnings call
Intraday BUY SELL Signals
BDSX
Price
$23.87
Change
+$0.47 (+2.01%)
Updated
Oct 20 closing price
Capitalization
251.86M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADPT vs BDSX

ADPT vs BDSX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADPT vs. BDSX commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and BDSX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADPT with price predictions
Oct 20, 2026

ADPT in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 07, 2026

ADPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 31 cases where ADPT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +9.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in 235 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 169 of 188 cases where ADPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for ADPT moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADPT as a result. In 73 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for ADPT turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 43 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

ADPT moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ADPT crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.270) is normal, around the industry mean (64.051). P/E Ratio (-61.050) is within average values for comparable stocks, (1.569). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (13.966) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

A.I.Advisor
a Summary for BDSX with price predictions
Oct 20, 2026

BDSX in -5.30% downward trend, falling for three consecutive days on October 19, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BDSX declined for three days, in 279 of 309 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BDSX as a result. In 76 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Moving Average Convergence Divergence Histogram (MACD) for BDSX turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 42 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

BDSX moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BDSX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDSX advanced for three days, in 198 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

BDSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 182 of 198 cases where BDSX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. BDSX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.543) is normal, around the industry mean (64.051). P/E Ratio (-7.700) is within average values for comparable stocks, (1.569). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.463) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADPT vs BDSX: Fundamental Ratings
ADPT
BDSX
OUTLOOK RATING
1..100
6576
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4035
P/E GROWTH RATING
1..100
5465
SEASONALITY SCORE
1..100
14n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADPT's Valuation (20) in the Hospital Or Nursing Management industry is in the same range as BDSX (47) in the null industry. This means that ADPT’s stock grew similarly to BDSX’s over the last 12 months.

ADPT's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as BDSX (100) in the null industry. This means that ADPT’s stock grew similarly to BDSX’s over the last 12 months.

ADPT's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as BDSX (100) in the null industry. This means that ADPT’s stock grew similarly to BDSX’s over the last 12 months.

BDSX's Price Growth Rating (35) in the null industry is in the same range as ADPT (40) in the Hospital Or Nursing Management industry. This means that BDSX’s stock grew similarly to ADPT’s over the last 12 months.

ADPT's P/E Growth Rating (54) in the Hospital Or Nursing Management industry is in the same range as BDSX (65) in the null industry. This means that ADPT’s stock grew similarly to BDSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTBDSX
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (ADPT: $24.42 vs. BDSX: $23.87)
Brand notoriety: ADPT: Notable vs. BDSX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ADPT: 54% vs. BDSX: 39%
Market capitalization -- ADPT: $3.9B vs. BDSX: $251.86M
ADPT [@Medical Specialties] is valued at $3.9B. BDSX’s [@Medical Specialties] market capitalization is $251.86M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 1 FA rating(s) are green while BDSX’s FA Score has 0 green FA rating(s).

  • ADPT’s FA Score: 1 green, 4 red.
  • BDSX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADPT and BDSX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while BDSX’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 6 bearish.
  • BDSX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BDSX is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Medical Specialties) experienced а -3.40% price change this week, while BDSX (@Medical Specialties) price change was -4.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.12%. For the same industry, the average monthly price growth was -4.99%, and the average quarterly price growth was +43.90%.

Reported Earning Dates

ADPT is expected to report earnings on Nov 04, 2026.

BDSX is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Medical Specialties (-1.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
ADPT
Daily Signal:
Gain/Loss:
BDSX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIYY11.200.35
+3.23%
YieldMax HIMS Option Income Strategy ETF (HIYY)
IQDG42.470.35
+0.83%
WisdomTree International Quality Dividend Growth Fund (IQDG)
EZU65.620.49
+0.75%
iShares MSCI Eurozone ETF (EZU)
MAMB23.280.05
+0.21%
Monarch Ambassador Income Index ETF (MAMB)
PMIO49.460.10
+0.20%
PGIM Municipal Income Opportunities ETF (PMIO)

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+1.96%
AXON - ADPT
56%
Loosely correlated
+2.49%
PSNL - ADPT
55%
Loosely correlated
+0.38%
NTRA - ADPT
55%
Loosely correlated
+1.63%
VCYT - ADPT
54%
Loosely correlated
+2.26%
ARRY - ADPT
50%
Loosely correlated
+2.15%
More